GleamWall
中文EN

DNTH Dianthus Therapeutics, Inc. /DE/

Pharmaceutical Preparations · Nasdaq · SEC CIK 1690585 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-67.3%
TTM net income YoY-91.1%
TTM EPS YoY-64.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-8,739.3%
Net margin-7,973.3%
FCF margin-6,349.4%
EBITDA margin-8,733.9%

Returns

ROE-38.4%
ROA-35.9%
ROIC (approx.)-36.4%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets7.1%
Debt / equity0.00x
Current ratio13.32x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.80x
Accruals ratio-7.4%
Payout ratio—
Capex / revenue10.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.04M$6.24M
R&D expense$145.64M$83.11M
SG&A expense$34.33M$24.99M
Operating income-$177.93M-$101.86M
Income tax$0$0
Net income-$162.34M-$84.97M
EBITDA-$177.82M-$101.77M
EPS (basic)-4.20-2.55
EPS (diluted)-4.20-2.55
Dividends declared per share0.000.00
Weighted avg. shares (diluted)38.62M33.31M
Balance sheet
Cash & equivalents$51.09M$23.02M
Short-term investments$353.21M$252.45M
Receivables$52,000$0
Current assets$409.44M$280.90M
PP&E, net$296,000$194,000
Total assets$530.92M$374.01M
Current liabilities$30.73M$18.45M
Total liabilities$37.52M$21.53M
Shareholders' equity$493.40M$352.48M
Shares outstanding43.22M31.12M
Cash flow statement
Operating cash flow-$129.06M-$78.18M
Capital expenditure$213,000$105,000
Free cash flow-$129.27M-$78.28M
Investing cash flow-$122.83M-$286.81M
Financing cash flow$280.12M$255.62M
Depreciation & amortization$111,000$96,000
Stock-based compensation$22.79M$12.89M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.